According to a new study on the safety of antipsychotic medications, the use of dopamine antagonists is associated with an increased risk of breast cancer. Published in this month's issue of Archives of General Psychiatry, the study, conducted by researchers from Brigham and Women's Hospital in Boston, analyzed more t